R-lansoprazole compositions and methods

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/44 (2006.01) A61K 31/4439 (2006.01)

Patent

CA 2320963

Methods and compositions are disclosed utilizing optically pure (+) lansoprazole for the treatment of ulcers in humans while substantially reducing the concomitant liability of adverse effects associated with the racemic mixture of lansoprazole. The optically pure (+) isomer is also useful for the treatment of gastroesophageal reflux. (+) lansoprazole is an inhibitor of H+ release and is therefore useful in the treatment of other conditions related to gastric hypersecretion such as Zollinger-Ellison Syndrome.

La présente invention concerne des compositions et des procédés d'utilisation du (+)-lansoprazole optiquement pur permettant le traitement d'ulcères chez l'homme, tout en réduisant notablement le risque concomitant d'effets secondaires associés à l'utilisation du mélange racémique de lansoprazole. L'isomère (+) optiquement pur est aussi utile dans le traitement des reflux gastro-oesophagiens. Comme le (+)-lansoprazole est un inhibiteur de libération d'H?+¿, il permet de traiter d'autres troubles liés à l'hypersécrétion gastrique, tels que le syndrome de Zollinger-Ellison.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

R-lansoprazole compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with R-lansoprazole compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and R-lansoprazole compositions and methods will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1485558

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.